Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
3 drugs in development
By Therapeutic Area
top 4
R&D Momentum
59/100
Pipeline Velocity
25/100
Trial Completion Rate
62/100
Pipeline Concentration
33/100
Pipeline Freshness
28/100
Strategic Signals
Activity
Last 14 days
Pilot Testing of a Patient-provider Decision Aid for HIV Post-exposure Prophylaxis Following Sexual Assault
Treatment Outcomes and Brain Mechanisms Associated With Non-Invasive Neuromodulation in Post-Stroke Aphasia
FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers
Impact of Group Participation on Adults With Aphasia
Oxygen Delivery in CPAP and Its Relationship With Regional Lung Ventilation in Preterm Infants
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)